Metabolic Syndrome and Cancer Project (Me-Can)
The Me-Can project was initiated in 2006 in order to create a large pooled cohort to investigate factors of metabolic syndrome on the association with cancer risk. Existing cohorts in Norway, Austria, and Sweden were included in the project. The cohorts were: in Norway, the Oslo Study I (Oslo), the Norwegian Counties Study (NCS), the Cohort of Norway (CONOR), and the Age 40 programme (40-years); in Austria, the Vorarlberg Health Monitoring and Prevention Programme (VHM&PP); and in Sweden, the Västerbotten Intervention Project (VIP), and the Malmö Preventive Project (MPP). Altogether, the Me-Can study file includes 940,060 subjects with data from over 1.6 million health examinations. After data cleaning and selection of subjects and observations, data from a total of 578,700 subjects is used in Me-Can studies.
Study design
Cohort
Number of participants at first data collection
578,700 (participants)
Recruitment is ongoing
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2006 (Me-Can inception)
1972 (Oslo)
1974 (NCS)
1995 (CONOR)
1994 (40-years)
1988 (VHM&PP )
1985 (VIP)
1974 (MPP)
Primary Institutions
Umeå University (Umeå Universitet)
Links
Profile paper DOI
Funders
Austrian National Bank (Oesterreichische Nationalbank, OeNB)
Swedish Cancer Society
World Cancer Research Fund (WCRF)
Ongoing?
Yes
Data types collected
- Secondary data
- None
- None
- Census data
- Existing research data
- Healthcare data
- Mortality data
Engagement
Keywords
